LAURUSLABS.NS
Laurus Labs Ltd
Price:  
620.55 
INR
Volume:  
2,536,670.00
India | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LAURUSLABS.NS WACC - Weighted Average Cost of Capital

The WACC of Laurus Labs Ltd (LAURUSLABS.NS) is 14.0%.

The Cost of Equity of Laurus Labs Ltd (LAURUSLABS.NS) is 14.50%.
The Cost of Debt of Laurus Labs Ltd (LAURUSLABS.NS) is 9.25%.

Range Selected
Cost of equity 13.30% - 15.70% 14.50%
Tax rate 25.80% - 27.40% 26.60%
Cost of debt 9.10% - 9.40% 9.25%
WACC 12.8% - 15.1% 14.0%
WACC

LAURUSLABS.NS WACC calculation

Category Low High
Long-term bond rate 6.9% 7.4%
Equity market risk premium 8.3% 9.3%
Adjusted beta 0.78 0.85
Additional risk adjustments 0.0% 0.5%
Cost of equity 13.30% 15.70%
Tax rate 25.80% 27.40%
Debt/Equity ratio 0.08 0.08
Cost of debt 9.10% 9.40%
After-tax WACC 12.8% 15.1%
Selected WACC 14.0%

LAURUSLABS.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for LAURUSLABS.NS:

cost_of_equity (14.50%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.78) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.